Great initiative. Here's a comprehensive guide to finding inspection information: For 503B Outsourcing Facilities (FDA-regulated): 1. FDA Inspection Database: - Go to FDA.gov → Inspections, Compliance → Inspection Observations - Search by company name - You can find Form 483s (inspection observations) and Warning Letters - Note: not all inspections result in public 483s; only inspections with findings 2. FDA Warning Letters Database: - FDA.gov → Inspections, Compliance → Warning Letters - Searchable by company, date, subject - These are serious — a Warning Letter means the FDA found significant violations 3. FDA Registered Outsourcing Facilities List: - Shows registration status but not detailed inspection results - Still useful to confirm they're actually registered 4. FOIA (Freedom of Information Act): - You can request specific inspection records via FOIA - Takes 1-3 months typically - Go to FDA.gov → About FDA → FOIA For 503A Pharmacies (State-regulated): 5. State Board of Pharmacy: - Every state has a board of pharmacy website - Most have a licensee lookup with discipline/enforcement history - Some states publish inspection reports; others only publish formal actions - For Mississippi specifically: Mississippi Board of Pharmacy website has a licensee verification tool 6. State Health Department: - Some states have separate health department oversight for sterile compounding - May have additional inspection records

Incredible, thank you. I just searched the FDA warning letters database and... my pharmacy received a Warning Letter 14 months ago. For "insanitary conditions" and "lack of process validation." My stomach just dropped. The letter specifically mentioned: - Failure to establish adequate cleaning and sanitizing procedures - Failure to adequately test components - Products distributed before completion of sterility testing Is this as bad as it sounds?

I won't sugarcoat it — an FDA Warning Letter for those specific findings is serious. Let me break down what each one means: "Failure to establish adequate cleaning and sanitizing procedures" — Their cleanroom may not have been maintained to the standards required for sterile compounding. This directly impacts the sterility of every product produced during the period of non-compliance. "Failure to adequately test components" — They may not have been properly testing the raw materials (API, excipients) coming in. This means you don't know for certain that the active ingredient is what it says it is, at the concentration it claims. "Products distributed before completion of sterility testing" — This is perhaps the most alarming. Sterility testing per USP <71> takes 14 days. Some facilities do a shorter "preliminary" release but are supposed to have a procedure for recalls if the 14-day test fails. Distributing without ANY sterility testing is reckless. Now, the important follow-up question: what has the pharmacy done SINCE the Warning Letter? The FDA typically expects a corrective action response within 15 business days. Some pharmacies genuinely clean up their act. Others don't, and face further enforcement. Check if there's been a follow-up inspection or any further enforcement actions.

I track FDA enforcement actions against compounding pharmacies as part of my work. A few things to add: 1. Warning Letters are public. The pharmacy can't hide them. They're permanently on the FDA's website. 2. The response to the Warning Letter is NOT public unless obtained via FOIA. So you can't easily see what corrective actions they claimed to take. 3. Follow-up inspections are common within 6-18 months after a Warning Letter. The results of the follow-up may or may not be public depending on whether new observations were made. 4. Escalation pathway: Warning Letter → Consent Decree → Injunction → Seizure. If you see a company progress past the Warning Letter stage, they've failed to adequately address the FDA's concerns. 5. Some data points to check: - FDA's Compounding Risk Alert page (lists products recalled or flagged) - FDA's Drug Recalls database - Your state board's disciplinary action records For your specific situation: a 14-month-old Warning Letter with those findings is concerning. I'd want to see evidence that they've corrected the issues before continuing to use them. Call them directly and ask: "I've seen the FDA Warning Letter from [date]. What corrective actions have you taken, and have you had a follow-up FDA inspection?" Their response will tell you a lot.